Brainstorm Cell Therapeutics Inc. (BCLI)
OTCMKTS · Delayed Price · Currency is USD
0.6995
+0.0045 (0.65%)
At close: Feb 27, 2026
Brainstorm Cell Therapeutics Employees
Brainstorm Cell Therapeutics had 23 employees as of September 30, 2025. The number of employees decreased by 6 or -20.69% compared to the same quarter last year.
Employees
23
Change
-6
Growth
-20.69%
Revenue / Employee
n/a
Profits / Employee
-$471,565
Market Cap
7.72M
Employees Chart
Employees History
Brainstorm Cell Therapeutics News
- 3 days ago - Brainstorm Cell Therapeutics Secures Second $1 Million Strategic Placement; Total $2 Million Raised In February - PRNewsWire
- 9 days ago - Brainstorm Cell Therapeutics Announces $1 Million Strategic Financing at Premium to Market - PRNewsWire
- 3 months ago - BrainStorm Cell Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 4 months ago - Halper Sadeh LLC Encourages Brainstorm Cell Therapeutics Inc. Shareholders to Contact the Firm to Discuss Their Rights - Business Wire
- 7 months ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2025 Financial Results and Provides Corporate Update - PRNewsWire
- 7 months ago - BrainStorm to Announce Second Quarter Financial Results and Provide a Corporate Update - PRNewsWire
- 8 months ago - BrainStorm Cell Therapeutics Announces Nasdaq Delisting and Transition to OTCQB - PRNewsWire